홈 › 대장직장암 › 텍사스 › San Antonio
TX San Antonio의 대장직장암 임상 시험
대장직장암 관련 연구 46개가 San Antonio 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
피험자 모집 중1/2상
- New Experimental Therapeutics of San Antonio - NEXT Oncology, San Antonio
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
피험자 모집 중관찰 연구건강한 지원자 환영
- Audie L Murphy VA Hospital, San Antonio
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
피험자 모집 중1상
- University of Texas San Antonio (UTSA), San Antonio
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
피험자 모집 중3상
- Texas Oncology - San Antonio, San Antonio
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
피험자 모집 중3상
- Texas Oncology - San Antonio, San Antonio
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
피험자 모집 중1상
- START San Antonio, San Antonio
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
피험자 모집 중2/3상
- Texas Oncology - San Antonio, San Antonio
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
피험자 모집 중1/2상
- NEXT Oncology San Antonio, San Antonio
- START Texas, San Antonio
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
피험자 모집 중1상
- NEXT, San Antonio
- START - San Antonio, San Antonio
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
피험자 모집 중1/2상
- START San Antonio, San Antonio
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
피험자 모집 중1상
- NEXT Oncology, San Antonio
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
피험자 모집 중3상
- Texas Oncology- San Antonio, San Antonio
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
피험자 모집 중2상
- Mays Cancer Center at University of Texas Health at San Antonio, San Antonio
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
피험자 모집 중1상
- NEXT San Antonio, San Antonio
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
피험자 모집 중1상
- NEXT Oncology, San Antonio
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
피험자 모집 중1상
- South Texas Accelerated Research Therapeutics (START), San Antonio
FOG-001 in Locally Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- UT Health Mays Cancer Center, San Antonio
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- Clinical Trial Site, San Antonio
IDOV-Immune for Advanced Solid Tumors
피험자 모집 중1상
- South Texas Accelerated Research Therapeutics, San Antonio
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
피험자 모집 중1/2상
- GSK Investigational Site, San Antonio
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
피험자 모집 중1/2상
- NEXT Oncology, San Antonio
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- Texas Oncology - San Antonio, San Antonio
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- Next Oncology, San Antonio
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
피험자 모집 중1상
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- START San Antonio, San Antonio
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
피험자 모집 중1상
- START San Antonio, LLC., San Antonio
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
피험자 모집 중1상
- New Experimental Therapeutics of San Antonio LLC, San Antonio
- START - South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
피험자 모집 중1/2상
- Next Oncology-Oncology, San Antonio
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
피험자 모집 중1상
- NEXT Oncology, San Antonio
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
피험자 모집 중1상
- NEXT Texas LLC - San Antonio, San Antonio
- START San Antonio, LLC, San Antonio
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
피험자 모집 중1상
- NEXT Texas LLC - San Antonio, San Antonio
- Start San Antonio, LLC, San Antonio
CT-95 in Advanced Cancers Associated With Mesothelin Expression
피험자 모집 중1상
- Context Investigational Site, San Antonio
- Context Investigational Site, San Antonio
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
피험자 모집 중1상
- Research Site #2, San Antonio
- Research Site, San Antonio
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
피험자 모집 중1상
- START, San Antonio
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
피험자 모집 중1상
- NEXT Oncology, San Antonio
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
피험자 모집 중1/2상
- NEXT Oncology, San Antonio
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
피험자 모집 중1/2상
- Next Oncology, San Antonio
A Study of MGC028 in Participants With Advanced Solid Tumors
피험자 모집 중1상
- South Texas Accelerated Research Therapeutics (START) San Antonio, San Antonio
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
피험자 모집 중1/2상
- NEXT Oncology, San Antonio
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
피험자 모집 중1상
- NEXT Oncology, San Antonio
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
피험자 모집 중1상
- NEXT Oncology, San Antonio
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
피험자 모집 중1/2상
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
- UT Health San Antonio, San Antonio
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- START San Antonio, San Antonio
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
피험자 모집 중1/2상
- START San Antonio, San Antonio
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
피험자 모집 중1/2상
- Next Oncology, San Antonio, San Antonio
다른 도시의 대장직장암 시험
- Houston, TX연구 102개
- New York City, NY연구 78개
- Nashville, TN연구 69개
- Boston, MA연구 63개
- Los Angeles, CA연구 59개
- Arlington, VA연구 52개
- St. Louis, MO연구 50개
- Philadelphia, PA연구 44개
- Grand Rapids, MI연구 40개
- Baldwin Park, CA연구 37개
- Chicago, IL연구 34개
- Tampa, FL연구 34개
San Antonio의 다른 연구
- 비소세포폐암연구 59개
- 유방암연구 47개
- 전이성 암연구 44개
- 암 (전체)연구 41개
- 비만연구 40개
- 제2형 당뇨병연구 37개
- 과체중연구 34개
- 난소암연구 31개
- 췌장암연구 31개
- 전립선암연구 28개
- 자궁내막암연구 27개
- 폐암연구 26개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.